NEUTREXIN

DEAD

Serial Number

74335524

Owner

MEDIMMUNE, LLC

Attorney

Wm. Charles Saunders

First Use Date

Jan 3, 1994

Filing Date

Nov 30, 1992

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NEUTREXIN Trademark

Serial Number: 74335524 • Registration: 1865146

NEUTREXIN is a trademark filed by MEDIMMUNE, LLC on November 30, 1992. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

MEDIMMUNE, LLC (39 trademarks)

ONE MEDIMMUNE WAY
GAITHERSBURG, MD 20878

Entity Type: 16

U.S. BIOSCIENCE, INC. (7 trademarks)

UNION MEETING CORPORATE CENTER, P.O. BOX
BLUE BELL, PA 19422

Entity Type: 03

MEDIMMUNE ONCOLOGY, INC. (5 trademarks)

ONE TOWER BRIDGE, SUITE 400
WEST CONSHOHOCKEN, PA 19428

Entity Type: 03

Legal Representation

Attorney of Record

Wm. Charles Saunders

771 trademarks filed View all →

Trademark Details

Filing Date

November 30, 1992

Registration Date

November 29, 1994

First Use Anywhere

January 3, 1994

First Use in Commerce

January 3, 1994

Published for Opposition

August 17, 1993

Cancellation Date

April 3, 2020

Goods & Services

pharmaceutical preparation for the treatment of cancer, psoriasis, arthritis, auto-immune diseases and warts (condylomata) and for the treatment and/or prophalaxis administration to prevent or treat pneumocystis carinii pneumonia, toxoplasmosis, and cryptosporidium

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Apr 3, 2020 CAEX

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Aug 6, 2008 ASGN

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 27, 2008 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 27, 2008 REAP

CASE FILE IN TICRS

Jul 16, 2007 CFIT

REVIEW OF CORRESPONDENCE COMPLETE

Sep 1, 2006 CORV

PAPER RECEIVED

Aug 21, 2006 MAIL

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jan 18, 2005 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jan 18, 2005 89AG

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

Nov 23, 2004 89AF

TEAS SECTION 8 & 9 RECEIVED

Nov 23, 2004 E89R

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 10, 2001 C15A

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Nov 7, 2000 815F

REGISTERED-PRINCIPAL REGISTER

Nov 29, 1994 R.PR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 29, 1994 CNPR

ASSIGNED TO EXAMINER

Aug 25, 1994 DOCK

STATEMENT OF USE PROCESSING COMPLETE

Aug 19, 1994 SUPC

USE AMENDMENT FILED

Jul 13, 1994 IUAF

NOA MAILED - SOU REQUIRED FROM APPLICANT

May 3, 1994 NOAM

PUBLISHED FOR OPPOSITION

Aug 17, 1993 PUBO

NOTICE OF PUBLICATION

Jul 16, 1993 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 17, 1993 CNSA

ASSIGNED TO EXAMINER

Jun 17, 1993 DOCK

ASSIGNED TO EXAMINER

Jun 14, 1993 DOCK

NON-FINAL ACTION MAILED

Feb 26, 1993 CNRT

ASSIGNED TO EXAMINER

Feb 19, 1993 DOCK

Related Trademarks

More from this Owner

MEDIMMUNE

More in Same Class

VITAMIN Q10